#243 Diabetes Triple Distilled
Listen in as we recap four of our favorite diabetes episodes to bring you the pearls you need to stay up to date on type 2 diabetes management in the clinic. We cover pitfalls of A1c testing, guidelines for A1C targets, when and how to use the newer medications SGLT-2 inhibitors and GLP-1 agonists. We wrap up with a discussion of managing DM2 in patients with kidney disease and in which patients to consider de-intensifying treatment. Feel confident managing diabetes with the latest data in 2020!
Listeners can claim 4 HOURS of Free CE credit for this episode through VCU Health at _http://curbsiders.vcuhealth.org/_ (CME goes live at 0900 ET on the episode’s release date).
_Show Notes_ | _Spotify_ | _Swag!_ | _Top Picks_ | _Mailing List_ | email@example.com_ | _CME!_
* Written and Produced by: Molly Heublein, MD
* Infographic and Cover Art: Isabel Valdez, PA
* Show Notes: Isabel Valdez, PA; Molly Heublein, MD
* Hosts: Stuart Brigham MD; Matthew Watto MD, FACP; Paul Williams MD, FACP, Molly Heublein, MD
* Editors: Emi Okamoto MD (written materials); Clair Morgan of _nodderly.com_
ACP’s I Raise the Rates
Join with other clinicians in working to raise influenza and other adult vaccination rates. Visit _acponline.org/ai_ to access free tools and learn new strategies to support your efforts.
VCU Health CE
The Curbsiders are partnering with _VCU Health Continuing Education_ to offer FREE continuing education credits for physicians and other healthcare professionals. Visit _curbsiders.vcuhealth.org_ and search for this episode to claim credit. See _info sheet _for further directions. Note: A free VCU Health CloudCME account is required in order to seek credit._
2:45 Pitfalls of A1c testing,
7:00 Diabetes goals/A1c guidelines; Macrovascular vs Microvascular benefits,
16:20 Choosing between SGLT2 inhibitors vs GLP1 agonists,
19:10 Stuart rants on insulin for symptomatic hyperglycemia,
22:32 Start your patient on an SGLT2i and counsel them about potential adverse events,
30:30 GLP-1 agonists,
36:50 Deintensification; Diabetes Treatment in CKD,
Diabetes, hypoglycemia, SGLT2 inhibitors, GLP-1 agonist, metformin, CKD, primary care, assistant, doctor, education, family, health, hospitalist, hospital, internal, internist, meded, medical, medicine, nurse, practitioner, professional, physician, resident, student